Number of the records: 1
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
- 1.
SYSNO ASEP 0559889 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Prodrugs of prostate specific membrane antigen (PSMA) inhibitor Author(s) Slusher, B. (US)
Rais, R. (US)
Krečmerová, Marcela (UOCHB-X) RID, ORCID
Tichý, Tomáš (UOCHB-X) RID
Majer, Pavel (UOCHB-X)
Jančařík, Andrej (UOCHB-X) ORCID, RIDYear of issue 2022 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. US11325931 Date of the patent acceptance 10.05.2022 Name of the patent owner The Johns Hopkins University - Ústav organické chemie a biochemie AV ČR, v. v. i. Code of the issuer name US001 - United States Patent and Trademark Office (USPTO) Alexandria Current use B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem Language eng - English Keywords 2-Phosphonomethylpentanedioic acid (2-PMPA) ; glutamate carboxypeptidase II ; GCPII ; PSMA ; pivaloyloxymethyl ; isopropyloxycarbonyloxymethyl ; POM ; POC ; prodrug OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation Methods and compounds are disclosed for treating a disease or condition by inhibiting PSMA (Prostate Specific Membrane Antigen) using prodrugs of 2-PMPA. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2023 Electronic address https://worldwide.espacenet.com/patent/search/family/055264571/publication/US11325931B2?q=US11325931B2
Number of the records: 1